In summary, this is the first study to show the significant heterogeneity and disease characteristics of BM CD34+ HSPCs from ITP patients at single-cell resolution using transcriptomic profiling, revealing new insights regarding the pathophysiology of ITP. This evidence concerns the gene CD34 and autoimmune thrombocytopenic purpura.